SecBot SecBot
144 ·Filed Aug 4, 2026

CDNA

CareDx, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001958244-26-000483
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for subsequent Form 4 filings to confirm actual execution of the sale. The modest size and director status suggest limited market impact, but continued insider distribution could indicate sentiment shift. Compare against next earnings for any correlation.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$45.50
T+0 close · Aug 4, 2026 · via day close
Latest settled
+3.98%
T+5 · $47.31
Vs SPY
+3.63%
α at T+5
Next horizon
T+20
due 3mo ago
  1. T+0 · Aug 5 $45.50entry
  2. T+1 · 3mo ago −1.52%α −1.36% · $44.81
  3. T+5 · 3mo ago +3.98%α +3.63% · $47.31
  4. T+20 · due 3mo ago Pending
  5. T+60 · due 19d ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Christine Cournoyer filed a Form 144 notice to sell 16,000 common shares of CareDx with an estimated market value of $753,440. The shares were acquired as RSU compensation in 2025. The proposed sale is small relative to CareDx's $2.5B market cap (0.03%) and represents routine insider diversification.

Key Facts

  • Director Christine Cournoyer intends to sell 16,000 shares via Goldman Sachs.
  • Estimated market value of proposed sale is $753,440.
  • Shares were acquired as RSU compensation on 06/14/2025 (10,570 shares) and 03/07/2025 (5,430 shares).
  • The sale represents less than 0.03% of CareDx's market capitalization.
  • Recent insider activity (30d) shows 3 other sells totaling $2.8M.

Financial Impact

Proposed sale of $753,440 in common stock by a director.

dilutioninsider holdings

Risk Factors

  • Further insider selling could weigh on sentiment.
  • No explicit catalyst tied to the filing, sale may be personal financial planning.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
62% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001958244-26-000483
Document: 0001958244-26-000483-index.html0001958244-26-000483
Document: 0001958244-26-000483.txt0001958244-26-000483

Track record

16 reports on CDNA

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +28.28% at T+60 after the Apr 16, 2026 report. 3 of 5 went positive at some point.

Filters
  1. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $77.88 Now $73.72 −5.34% settles Feb 11
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $77.88 Now $73.72 −5.34% settles Feb 11
  3. Nov 10, 20266d ago 144 Neutral 2/10 Entry $81.17 Now $73.72 −9.18% settles Feb 9
  4. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $80.77 Now $73.72 −8.73% settles Feb 8
  5. Nov 5, 202611d ago 144 Neutral 3/10 Entry $78.56 Now $73.72 −6.16% settles Feb 4
  6. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $87.41 Now $73.72 −15.66% settles Jan 28
  7. Oct 29, 202618d ago Institutional Cluster Bearish 4/10 Entry $71.52 Now $73.72 −3.08% settles Jan 27
  8. Aug 6, 202614w ago Insider Cluster Neutral 3/10 Entry $46.69 to $86.54 Now $73.72 +57.89% ▲ +85.34% +87.47% vs SPY
  9. Aug 4, 202614w ago 144 Neutral 2/10 Viewing Entry $45.50 Now $73.72 +62.02% No price data
  10. Jul 17, 202617w ago Insider Cluster Neutral 4/10 Entry $39.73 Now $73.72 +85.55% No price data
Showing 10 of 16

US Market Status

Market Closed · Opens Wed (9h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 4, 2026